platinum has been researched along with Carcinogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anikin, IV; Anisimov, VN; Fedoros, EI; Gubareva, EA; Panchenko, AV; Pigarev, SE; Popovich, IG; Solovyev, ND; Tyndyk, ML; Yurova, MN | 1 |
| Petruzzelli, R; Polishchuk, RS | 1 |
1 review(s) available for platinum and Carcinogenesis
| Article | Year |
|---|---|
Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carcinogenesis; Cisplatin; Copper; Copper-Transporting ATPases; Drug Resistance, Neoplasm; Golgi Apparatus; Humans; Mice; Platinum | 2019 |
1 other study(ies) available for platinum and Carcinogenesis
| Article | Year |
|---|---|
Assessment of antitumor activity of BP-C1, a platinum-based anticancer agent with a lignin-derived polymeric ligand, in autochthonous induced and spontaneous carcinogenesis rodent models.
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzo(a)pyrene; Carcinogenesis; Carcinogens; Female; Ligands; Lignin; Mice; Mice, Inbred Strains; Platinum; Rats; Rats, Wistar; Rodentia | 2022 |